NewGenIvf Group PE Ratio 2023-2025 | NIVF
Current and historical p/e ratio for NewGenIvf Group (NIVF) from 2023 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. NewGenIvf Group PE ratio as of November 14, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| NewGenIvf Group PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-11-14 | 0.38 | 0.00 | |
| 2025-06-30 | 5.20 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.001B | $0.005B |
| NewGenIvf Limited is a comprehensive fertility services provider principally in Asia helping couples and individuals obtain access to fertility treatments. NewGenIvf, formerly known as A SPAC I Acquisition Corp., is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $156.245B | 28.69 |
| HCA Healthcare (HCA) | United States | $108.000B | 17.88 |
| CVS Health (CVS) | United States | $100.590B | 11.57 |
| Elevance Health (ELV) | United States | $72.957B | 10.70 |
| Cencora (COR) | United States | $70.853B | 22.85 |
| Natera (NTRA) | United States | $27.695B | 0.00 |
| DiDi Global (DIDIY) | China | $25.933B | 21.19 |
| Labcorp Holdings (LH) | United States | $22.206B | 16.93 |
| Medpace Holdings (MEDP) | United States | $16.656B | 41.35 |
| BioMerieux (BMXMF) | France | $15.266B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.321B | 0.00 |
| ICON (ICLR) | Ireland | $13.200B | 13.10 |
| Solventum (SOLV) | United States | $13.047B | 12.66 |
| Viatris (VTRS) | United States | $12.566B | 4.68 |
| CochLear (CHEOY) | Australia | $11.666B | 0.00 |
| Revvity (RVTY) | United States | $10.589B | 19.50 |
| HealthEquity (HQY) | United States | $8.573B | 34.31 |
| Charles River Laboratories (CRL) | United States | $8.328B | 16.04 |
| Avantor (AVTR) | United States | $7.977B | 12.19 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.856B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $6.816B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $5.726B | 34.14 |
| Bausch + Lomb (BLCO) | Canada | $5.557B | 36.49 |
| Sotera Health (SHC) | United States | $4.548B | 21.93 |
| Amplifon S.p.A (AMFPF) | Italy | $4.059B | 23.68 |
| GeneDx Holdings (WGS) | United States | $3.768B | 66.17 |
| Alignment Healthcare (ALHC) | United States | $3.356B | 0.00 |
| Concentras Parent (CON) | United States | $2.531B | 15.80 |
| Premier (PINC) | United States | $2.325B | 22.53 |
| Progyny (PGNY) | United States | $2.105B | 41.39 |
| Organon (OGN) | United States | $1.981B | 2.09 |
| Surgery Partners (SGRY) | United States | $1.980B | 25.52 |
| Pediatrix Medical (MD) | United States | $1.943B | 11.60 |
| Establishment Labs Holdings (ESTA) | $1.882B | 0.00 | |
| PACS (PACS) | United States | $1.631B | 0.00 |
| Ardent Health (ARDT) | United States | $1.331B | 4.35 |
| Teladoc Health (TDOC) | United States | $1.255B | 0.00 |
| Omada Health (OMDA) | $1.203B | 0.00 | |
| GoodRx Holdings (GDRX) | United States | $1.042B | 17.06 |
| Embecta (EMBC) | United States | $0.843B | 4.93 |
| CareDx (CDNA) | United States | $0.816B | 13.34 |
| InnovAge Holding (INNV) | United States | $0.727B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.617B | 8.50 |
| Nutex Health (NUTX) | United States | $0.604B | 9.15 |
| Sonida Senior Living (SNDA) | United States | $0.601B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.508B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| CryoPort (CYRX) | United States | $0.439B | 0.00 |
| Enhabit (EHAB) | United States | $0.412B | 18.52 |
| Strata Critical Medical (SRTA) | United States | $0.399B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.366B | 5.50 |
| So-Young (SY) | China | $0.365B | 0.00 |
| Pomdoctor - (POM) | China | $0.362B | 0.00 |
| SBC Medicals (SBC) | United States | $0.349B | 7.64 |
| Shoulder Innovations (SI) | United States | $0.303B | 0.00 |
| Oncology Institute (TOI) | United States | $0.288B | 0.00 |
| KindlyMD (NAKA) | United States | $0.275B | 0.00 |
| Agilon Health (AGL) | United States | $0.250B | 0.00 |
| LifeMD (LFMD) | United States | $0.219B | 0.00 |
| Beauty Health (SKIN) | United States | $0.166B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.157B | 26.99 |
| Ascend Wellness Holdings (AAWH) | United States | $0.129B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.111B | 0.00 |
| DocGo (DCGO) | United States | $0.102B | 0.00 |
| Biodesix (BDSX) | United States | $0.063B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.049B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.034B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.023B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.023B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.019B | 6.84 |
| SeaStar Medical Holding (ICU) | United States | $0.016B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| ISpecimen (ISPC) | United States | $0.006B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |